PARNAX LAB Financial Statement Analysis
|
||
|
The Revenues of PARNAX LAB have increased by 32.39% YoY .
The Earnings Per Share (EPS) of PARNAX LAB has increased by 2.19 % YoY. |
||
PARNAX LAB Last 5 Annual Financial Results
[BOM: 506128]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹249 Cr | ₹188 Cr | ₹189 Cr | ₹168 Cr | ₹163 Cr |
| Expenses | ₹221 Cr | ₹161 Cr | ₹165 Cr | ₹145 Cr | ₹140 Cr |
| Operating Profit (Excl OI) | ₹27 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹23 Cr |
| Other Income | ₹3.78 Cr | ₹1.68 Cr | ₹0.82 Cr | ₹0.77 Cr | ₹0.33 Cr |
| Interest | ₹5.71 Cr | ₹5.39 Cr | ₹5.35 Cr | ₹4.95 Cr | ₹5.23 Cr |
| Depreciation | ₹8.05 Cr | ₹7.38 Cr | ₹6.96 Cr | ₹6.53 Cr | ₹5.87 Cr |
| Profit Before Tax | ₹16 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| Profit After Tax | ₹12 Cr | ₹12 Cr | ₹9.63 Cr | ₹8.63 Cr | ₹8.26 Cr |
| Consolidated Net Profit | ₹12 Cr | ₹12 Cr | ₹9.61 Cr | ₹8.62 Cr | ₹8.24 Cr |
| Earnings Per Share (Rs) | ₹10.25 | ₹10.03 | ₹8.37 | ₹7.50 | ₹8.40 |
| PAT Margin (%) | 4.75 | 6.15 | 5.10 | 5.15 | 5.07 |
| ROE(%) | 13.24 | 14.92 | 14.39 | 15.91 | 20.93 |
| ROCE(%) | 13.79 | 14.71 | 13.61 | 15.20 | 17.34 |
| Total Debt/Equity(x) | 0.78 | 0.73 | 0.99 | 0.82 | 1.41 |
Key Financials |
||
| Market Cap | : | ₹ 118.5 Cr |
| Revenue (TTM) | : | ₹ 252.0 Cr |
| Net Profit(TTM) | : | ₹ 8.9 Cr |
| EPS (TTM) | : | ₹ 7.8 |
| P/E (TTM) | : | 13.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PARNAX LAB | -2.9% | -10.4% | -24.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.7% | 1.4% | 4.3% |
| DIVIS LABORATORIES | 4.5% | 6.3% | 50.8% |
| TORRENT PHARMACEUTICALS | 1.8% | -1.3% | 31.4% |
| CIPLA | 1.6% | 4.4% | -9.1% |
| DR REDDYS LABORATORIES | 0.8% | 12.5% | 14.1% |
| MANKIND PHARMA | 1.1% | 1.2% | 3.6% |
| LUPIN | -1.1% | -2.3% | 3.6% |
| ZYDUS LIFESCIENCES | -3.8% | 3.1% | 20.7% |
PARNAX LAB Revenues
[BOM: 506128]
| Y-o-Y | 32.39 % |
| 5 Yr CAGR | 11.12 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 32.39 | |
| Mar2025 | ₹188 Cr | -0.52 | |
| Mar2024 | ₹189 Cr | 12.59 | |
| Mar2023 | ₹168 Cr | 2.81 | |
| Mar2022 | ₹163 Cr | - | |
PARNAX LAB Operating Profit
[BOM: 506128]
| Y-o-Y | 1.81 % |
| 5 Yr CAGR | 4.30 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 1.81 | |
| Mar2025 | ₹27 Cr | 13.69 | |
| Mar2024 | ₹24 Cr | 2.42 | |
| Mar2023 | ₹23 Cr | -0.18 | |
| Mar2022 | ₹23 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -23.14 % |
| 5 Yr CAGR | -6.15 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 10.96% | -23.14 | |
| Mar2025 | 14.26% | 14.26 | |
| Mar2024 | 12.48% | -9.04 | |
| Mar2023 | 13.72% | -2.90 | |
| Mar2022 | 14.13% | - | |
PARNAX LAB Profit After Tax
[BOM: 506128]
| Y-o-Y | 2.24 % |
| 5 Yr CAGR | 9.33 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 2.24 | |
| Mar2025 | ₹12 Cr | 19.88 | |
| Mar2024 | ₹9.61 Cr | 11.50 | |
| Mar2023 | ₹8.62 Cr | 4.55 | |
| Mar2022 | ₹8.24 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -22.76 % |
| 5 Yr CAGR | -1.62 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 4.75 % | -22.76 | |
| Mar2025 | 6.15 % | 20.59 | |
| Mar2024 | 5.1 % | -0.97 | |
| Mar2023 | 5.15 % | 1.58 | |
| Mar2022 | 5.07 % | - | |
PARNAX LAB Earnings Per Share (EPS)
[BOM: 506128]
| Y-o-Y | 2.19 % |
| 5 Yr CAGR | 5.10 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹10 | 2.19 | |
| Mar2025 | ₹10 | 19.83 | |
| Mar2024 | ₹8.37 | 11.60 | |
| Mar2023 | ₹7.50 | -10.71 | |
| Mar2022 | ₹8.40 | - | |
PARNAX LAB Return on Capital Employed (ROCE)
[BOM: 506128]
| Y-o-Y | -6.25 % |
| 5 Yr CAGR | -5.57 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 13.79% | -6.25 | |
| Mar2025 | 14.71% | 8.08 | |
| Mar2024 | 13.61% | -10.46 | |
| Mar2023 | 15.2% | -12.34 | |
| Mar2022 | 17.34% | - | |
PARNAX LAB Share Price vs Sensex
| Current Share Price | : | ₹103.0 |
| Current MarketCap | : | ₹ 118.5 Cr |
| Updated EOD on | : | Nov 05,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | -2.9% |
-10.4% |
-24.4% |
| SENSEX | 7% |
9.6% |
-6.7% |
PARNAX LAB related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PARNAX LAB Financials
How the annual revenues of PARNAX LAB have changed ?
The Revenues of PARNAX LAB have increased by 32.39% YoY .
How the Earnings per Share (EPS) of PARNAX LAB have changed?
The Earnings Per Share (EPS) of PARNAX LAB has increased by 2.19 % YoY .
Check out Intrinsic Value of Peers of PARNAX LAB
Compare Stock Analytics of Peers of PARNAX LAB
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
